Coloplast A/S (LON:0QBO)

Market Cap	11.24B -39.7%
Revenue (ttm)	3.26B +1.6%
Net Income	465.95M -18.3%
EPS	2.07 -18.4%
Shares Out	n/a
PE Ratio	24.11
Forward PE	16.67
Dividend	2.67 (0.61%)
Ex-Dividend Date	Dec 5, 2025

Volume	14,887
Average Volume	70,036
Open	438.15
Previous Close	438.80
Day's Range	428.60 - 439.14
52-Week Range	416.00 - 748.00
Beta	0.55
RSI	37.62
Earnings Date	May 12, 2026

About Coloplast

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories ...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1954
• Employees: 16,983
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QBO

Financial Performance

In fiscal year 2025, Coloplast's revenue was 27.87 billion, an increase of 3.12% compared to the previous year's 27.03 billion. Earnings were 3.64 billion, a decrease of -28.03%.

Financial numbers in DKK